189 related articles for article (PubMed ID: 26628298)
1. Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis.
Liu X; Kang J; Liu F; Wen S; Zeng X; Liu K; Luo Y; Ji X; Zhao S
Tumour Biol; 2016 May; 37(5):6323-30. PubMed ID: 26628298
[TBL] [Abstract][Full Text] [Related]
2. iASPP, a microRNA‑124 target, is aberrantly expressed in astrocytoma and regulates malignant glioma cell migration and viability.
Liu X; Kang J; Sun S; Luo Y; Ji X; Zeng X; Zhao S
Mol Med Rep; 2018 Jan; 17(1):1970-1978. PubMed ID: 29257240
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of iASPP correlates with poor prognosis and chemoresistance/radioresistance in FIGO Ib1-IIa squamous cell cervical cancer.
Cao L; Huang Q; He J; Lu J; Xiong Y
Cell Tissue Res; 2013 May; 352(2):361-9. PubMed ID: 23420450
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic iASPP expression as a novel prognostic indicator in oral cavity squamous cell carcinoma.
Kim JW; Roh JL; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Feb; 22(2):662-9. PubMed ID: 25149434
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Inhibition of Apoptosis-Stimulating Protein of p53 (iASPP) Suppresses Cisplatin-Resistant Gastric Carcinoma In Vitro.
Yu J; Li L; Huang C
Med Sci Monit; 2017 Nov; 23():5542-5549. PubMed ID: 29161238
[TBL] [Abstract][Full Text] [Related]
6. Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.
Wang P; Ye JA; Hou CX; Zhou D; Zhan SQ
Oncol Rep; 2016 Nov; 36(5):2544-2552. PubMed ID: 27633132
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of iASPP Expression Suppresses Proliferation, Invasion and Increases Chemosensitivity to Paclitaxel of Head and Neck Squamous Cell Carcinoma
Liu ZZ; Kuang WL; Zeng WJ; Xiao JY; Tian YQ
Chin Med Sci J; 2019 Sep; 34(3):184-193. PubMed ID: 31601301
[TBL] [Abstract][Full Text] [Related]
8. The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting iASPP.
He Z; Wang Y; Huang G; Wang Q; Zhao D; Chen L
Arch Biochem Biophys; 2017 Jun; 623-624():1-8. PubMed ID: 28137422
[TBL] [Abstract][Full Text] [Related]
9. The Long Noncoding RNA TP73-AS1 Interacted with miR-124 to Modulate Glioma Growth by Targeting Inhibitor of Apoptosis-Stimulating Protein of p53.
Xiao S; Wang R; Wu X; Liu W; Ma S
DNA Cell Biol; 2018 Feb; 37(2):117-125. PubMed ID: 29412778
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel isoform of iASPP and its interaction with p53.
Zhang X; Diao S; Rao Q; Xing H; Liu H; Liao X; Wang M; Wang J
J Mol Biol; 2007 May; 368(4):1162-71. PubMed ID: 17391696
[TBL] [Abstract][Full Text] [Related]
12. iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe.
Jiang L; Siu MK; Wong OG; Tam KF; Lu X; Lam EW; Ngan HY; Le XF; Wong ES; Monteiro LJ; Chan HY; Cheung AN
Clin Cancer Res; 2011 Nov; 17(21):6924-33. PubMed ID: 21926165
[TBL] [Abstract][Full Text] [Related]
13. Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124.
Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Suzuki F; Yamada T; Kudo M; Yue J; Sakuragi N
Sci Rep; 2016 Oct; 6():35480. PubMed ID: 27765948
[TBL] [Abstract][Full Text] [Related]
14. Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas.
Li MY; Yang P; Liu YW; Zhang CB; Wang KY; Wang YY; Yao K; Zhang W; Qiu XG; Li WB; Peng XX; Wang YZ; Jiang T
Sci Rep; 2016 Feb; 6():21141. PubMed ID: 26879272
[TBL] [Abstract][Full Text] [Related]
15. Dec1 expression predicts prognosis and the response to temozolomide chemotherapy in patients with glioma.
Li XM; Lin W; Wang J; Zhang W; Yin AA; Huang Y; Zhang J; Yao L; Bian H; Zhang J; Zhang X
Mol Med Rep; 2016 Dec; 14(6):5626-5636. PubMed ID: 27840944
[TBL] [Abstract][Full Text] [Related]
16. Suppression of p53-inducible gene 3 is significant for glioblastoma progression and predicts poor patient prognosis.
Quan J; Li Y; Jin M; Chen D; Yin X; Jin M
Tumour Biol; 2017 Mar; 39(3):1010428317694572. PubMed ID: 28351326
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
[TBL] [Abstract][Full Text] [Related]
18. The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP.
Zhao H; Peng R; Liu Q; Liu D; Du P; Yuan J; Peng G; Liao Y
Arch Biochem Biophys; 2016 Nov; 610():1-7. PubMed ID: 27693036
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expressions of FHL2 and iASPP predict poor prognosis in acute myeloid leukemia.
Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Zhang Z; Qin T; Hu N; Zhang Y; Ke X; Chen Y; Wu D; Shi J; Fu L
Cancer Gene Ther; 2019 Feb; 26(1-2):17-25. PubMed ID: 29910468
[TBL] [Abstract][Full Text] [Related]
20. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]